CMG Pharmaceutical Co Ltd
KOSDAQ:058820
Shareholder Yield
Current shareholder yield for CMG Pharmaceutical Co Ltd is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
CMG Pharmaceutical Co Ltd
| Average Annual Return | -18.25% |
| Standard Deviation of Annual Returns | 23.77% |
| Max Drawdown | -71% |
| Market Capitalization | 291.8B KRW |
| Shares Outstanding | 147 840 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
CMG Pharmaceutical Co Ltd's latest stock split occurred on Jun 13, 2019
The company executed a 1709-for-1592 stock split, meaning that for every 1592 shares held, investors received 1709 new shares.
Before the split, CMG Pharmaceutical Co Ltd traded at 3665.0001 per share. Afterward, the share price was about 3535.
The adjusted shares began trading on Jun 13, 2019. This was CMG Pharmaceutical Co Ltd's 5th stock split, following the previous one in Sep 26, 2016.
